Schwab U.S. Dividend Equity ETF (SCHD) Delivers +6.7% 30-Day Gain on Defensive Income Tilt

Key Takeaways

• SCHD tracks the Dow Jones U.S. Dividend 100 Index, holding approximately 103 dividend-paying U.S. companies through a rules-based quality, yield, and dividend-growth screen.
• The ETF's latest 30-day price move was roughly +6.7%, a steady advance that remained below the threshold for high-momentum or high-volatility positioning.
• Over the most recent quarter, SCHD rose about 8.8% on a price basis, supported by health care, financials, information technology, and industrial sector strength within the portfolio.
• Health care, consumer staples, energy, and technology are the fund's largest sector exposures, giving the portfolio a defensive income tilt with select cyclical drivers.
• The fund carries a 0.06% expense ratio and manages roughly $100 billion in assets under management (AUM).
• Key considerations include sector concentration, value and dividend-style rotation, interest-rate expectations, and the earnings resilience of its largest holdings.

Schwab U.S. Dividend Equity ETF (SCHD) Overview

The SCHD is a passively managed exchange-traded fund designed to track the Dow Jones U.S. Dividend 100 Index. The index targets high-dividend-yielding U.S. companies with a record of consistent payouts, then applies fundamental screens based on financial strength relative to industry peers. This rules-based approach produces a portfolio of about 103 large-cap, dividend-paying stocks rather than a simple highest-yield list.

Largest positions recently included Abbott Laboratories, UnitedHealth Group, Merck, Home Depot, Amgen, Procter & Gamble, Coca-Cola, Chevron, PepsiCo, Verizon Communications, and Texas Instruments. Sector exposure is concentrated in health care, consumer staples, energy, and technology, with smaller allocations to financials, industrials, consumer discretionary, and communication services. The fund's low 0.06% expense ratio and quarterly distribution schedule reinforce its role as a cost-efficient equity income vehicle. I also checked this using Tickeron’s AI Screener to see how the ETF compares to peers in the dividend space.

Industry and Thematic Landscape

The broader market environment for dividend and equity income strategies has been defined by a rotation toward cash-flow-generative, fundamentally sound companies. Sectors such as health care and consumer staples offer defensive earnings streams, while energy and financials add sensitivity to commodity prices, credit conditions, and interest rates. Technology exposure within dividend strategies has also become more relevant as mature semiconductor and software-related companies return capital to shareholders.

For SCHD, this sector mix matters because the fund's performance is shaped less by a single macroeconomic theme and more by the interaction of defensive income demand, value rotation, and the earnings trajectory of large-cap dividend payers. In an environment where investors continue to evaluate inflation, monetary policy, and economic growth, quality dividend exposure has remained a central investment theme.

Performance and Positioning Snapshot

SCHD's latest available close of $34.52 compares with a close of roughly $32.34 about 30 calendar days earlier, representing a gain of approximately 6.7% on a price basis. The advance was gradual and trend-driven rather than volatile, with the fund moving steadily higher before consolidating near recent highs. Over the most recent quarter, SCHD advanced from about $31.72 to $34.52, a move of roughly 8.8%.

The fund's sector sleeve performance helps explain the trend. Health care, financials, information technology, and industrials were among the stronger areas within the portfolio during the latest quarter, while energy and consumer staples were more mixed. That combination allowed SCHD to benefit from defensive health care leadership and select cyclical recovery without depending entirely on a single sector. Major holdings in managed care, pharmaceuticals, home improvement retail, and semiconductors contributed to the fund's positioning during the period. I reviewed the latest signals on this using Tickeron’s AI Trend Prediction Engine to confirm the broader sector momentum.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to influence SCHD during 2026. The health care sector will remain important given the fund's largest exposure, with attention on pharmaceutical pipelines, managed-care pricing, and regulatory developments. Consumer staples performance will depend on pricing power, volume trends, and the ability of large branded companies to defend margins. Energy holdings remain tied to commodity prices, capital discipline, and global demand, while financials are sensitive to credit conditions and interest-rate expectations.

Technology exposure may be influenced by semiconductor demand, enterprise spending, and shareholder-return policies. Dividend growth, payout ratios, and any changes to the underlying index's selection methodology also matter for portfolio composition. Finally, capital flows into dividend ETFs, competition from lower-cost or higher-yield products, and the broader macroeconomic environment—including inflation trends, monetary policy, and economic growth—will help determine whether defensive income leadership persists or broadens. Investors should monitor these themes rather than rely on short-term price movements alone.

Tickeron AI Tools for Research

In my own analysis, I find Tickeron’s AI Screener particularly useful for quickly scanning dividend-focused ETFs and comparing sector exposures against broader market trends. The platform pulls together technical indicators, fundamentals, and AI-generated signals in one place, which helps streamline the process of evaluating holdings like those in SCHD without spending hours on manual screens. Explore the AI Screener to see how data-driven discovery can support a more disciplined research process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Contributor

Jimmy Landsman|Expert

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.

Notable companies

Industry description

Market Cap

High and low price notable news

Volume